The Prognostic Role of the Class III Β-Tubulin in Non-Small Cell Lung Cancer (NSCLC) Patients Receiving the Taxane/Vinorebine-Based Chemotherapy: A Meta-Analysis

PLoS ONE - United States
doi 10.1371/journal.pone.0093997
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Class III -Tubulin Mediates Sensitivity to Chemotherapeutic Drugs in Non Small Cell Lung Cancer

Cancer Research
Cancer ResearchOncology
2007English

Glasgow Prognostic Score in Patients Receiving Chemotherapy for Non-Small-Cell Lung Cancer in Stages IIIb and IV

Medicinski Arhiv
Medicine
2014English

P2.01-113 Prognostic Roles of Neoadjuvant and Adjuvant Chemotherapy for Treating Patients With Operable Stage III-N2 Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Prognostic Significance of Immune Cells in Non-Small Cell Lung Cancer: Meta-Analysis

Oncotarget
Oncology
2018English

High Expression of Class III Β-Tubulin Predicts Good Response to Neoadjuvant Taxane and Doxorubicin/Cyclophosphamide-Based Chemotherapy in Estrogen Receptor–Negative Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2013English

PCN37 Cost-Minimization Analysis of Second-Line Chemotherapy for Non-Small-Cell Lung Cancer (NSCLC)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Prognostic Role of Platelet to Lymphocyte Ratio in Non-Small Cell Lung Cancers: A Meta-Analysis Including 3,720 Patients

International Journal of Cancer
Cancer ResearchOncology
2016English

The Value of MicroRNA-155 as a Prognostic Factor for Survival in Non-Small Cell Lung Cancer: A Meta-Analysis

PLoS ONE
Multidisciplinary
2015English

Whole Brain Radiotherapy Plus Concurrent Chemotherapy in Non-Small Cell Lung Cancer Patients With Brain Metastases: A Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy